Loading...
XSHE002250
Market cap624mUSD
Jan 10, Last price  
5.09CNY
1D
-3.78%
1Q
-4.68%
Jan 2017
-68.54%
IPO
132.42%
Name

Lianhe Chemical Technology Co Ltd

Chart & Performance

D1W1MN
XSHE:002250 chart
P/E
P/S
0.71
EPS
Div Yield, %
5.77%
Shrs. gr., 5y
-0.17%
Rev. gr., 5y
9.38%
Revenues
6.44b
-18.10%
756,420,928908,890,797986,979,4861,084,937,9311,340,593,0591,973,449,0902,568,045,0312,955,361,7913,368,351,4133,990,266,0984,007,786,8723,099,309,7424,107,388,6284,114,127,8814,283,784,4634,781,798,7126,586,780,6857,865,465,5506,442,152,833
Net income
0k
-100.00%
38,739,68557,716,65658,249,67474,735,708129,559,767202,978,686294,334,952365,665,107449,559,079551,050,422638,072,408263,852,074201,341,17337,531,203195,983,032110,031,914315,405,020696,838,4390
CFO
1.08b
+68.67%
64,452,19697,212,38491,063,89621,264,558180,802,734186,191,609202,305,248501,702,908465,126,188633,714,625644,575,114547,797,623588,838,243537,120,1521,050,524,5831,379,278,348737,788,383638,760,8111,077,406,421
Dividend
Jul 12, 20240.02 CNY/sh
Earnings
May 22, 2025

Profile

Lianhe Chemical Technology Co., Ltd. develops, produces, markets, and sells chemical products in China. It offers crop protection products, performance chemicals, and pharmaceuticals, as well as a range of engineering services and equipment manufacturing services. The company was founded in 1985 and is based in Taizhou, China.
IPO date
Jun 19, 2008
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
6,442,153
-18.10%
7,865,466
19.41%
Cost of revenue
5,919,892
6,418,320
Unusual Expense (Income)
NOPBT
522,261
1,447,145
NOPBT Margin
8.11%
18.40%
Operating Taxes
27,468
208,273
Tax Rate
5.26%
14.39%
NOPAT
494,793
1,238,872
Net income
696,838
120.93%
Dividends
(264,180)
(46,162)
Dividend yield
3.98%
0.32%
Proceeds from repurchase of equity
(8,741)
(1)
BB yield
0.13%
0.00%
Debt
Debt current
804,111
1,981,213
Long-term debt
2,864,528
1,585,197
Deferred revenue
98,547
94,417
Other long-term liabilities
548,843
506,354
Net debt
2,708,247
2,793,718
Cash flow
Cash from operating activities
1,077,406
638,761
CAPEX
(1,055,141)
Cash from investing activities
(1,072,722)
Cash from financing activities
128,166
1,051,328
FCF
960,884
(672,338)
Balance
Cash
661,380
583,156
Long term investments
299,012
189,534
Excess cash
638,285
379,417
Stockholders' equity
4,580,823
5,049,574
Invested Capital
10,392,669
10,827,925
ROIC
4.66%
12.49%
ROCE
4.73%
12.90%
EV
Common stock shares outstanding
930,488
923,246
Price
7.13
-54.00%
15.50
-13.75%
Market cap
6,634,379
-53.64%
14,310,317
-13.75%
EV
9,659,371
17,370,704
EBITDA
1,297,514
2,041,449
EV/EBITDA
7.44
8.51
Interest
112,630
89,866
Interest/NOPBT
21.57%
6.21%